LPTX – leap therapeutics, inc. (US:NASDAQ)

News

Leap Therapeutics (NASDAQ:LPTX) is now covered by analysts at Weiss Ratings. They set a "sell (e+)" rating on the stock.
Solana in the Shade: Crypto Daybook Americas [Yahoo! Finance]
Will Winklevoss Twins Successfully Takeover ZCash? [Yahoo! Finance]
Winklevoss-backed stock halted multiple times after wild 550% rally [Yahoo! Finance]
BC-Most Active Stocks [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com